Company: PFSA
Filing Date: 2025-04-28
Form Type: S-4/A
Source: 0001213900-25-035718
Chunk: 246

Company: Profusa, Inc.
Filing Date: 2025-04-28
Form: S-4/A
Chunk 246
---
 upon the conversion of the PIPE Convertible Notes would dilute the ownership percentage of the Sponsor by between approximately 6.2% (assuming no redemption of NorthView Common Stock by Public Stockholders) and approximately 5.8% (assuming maximum redemption NorthView Common Stock by Public Stockholders), not including any NorthView Common stock that could be issued pursuant to the PIPE Subscription Agreement for the additional tranches of PIPE Convertible Notes. The potential PIPE Subscription Agreement benefits New Profusa by providing it with additional capital that could fund New Profusa’s operations and growth following the Business Combination, and thereby increase the value of New Profusa and the Public Shareholders’ holdings and their return on investment in NorthView. The diluted ownership percentages referenced above include the dilution from the PIPE Subscription Agreement. Ownership of New Profusa As of the date of this proxy statement/prospectus, there are 5,348,311shares of NorthView Common Stock issued and outstanding, which includes an aggregate of 4,743,750shares of NorthView Common Stock held by the Sponsor. In addition, as of the date of this proxy statement/prospectus, there is outstanding an aggregate of 17,404,250 warrants to acquire NorthView Common Stock, comprised of 7,347,500 private placement warrants held by the Sponsor and Representatives, 9,487,500 public warrants, and 569,250 Representative Warrants. Each whole warrant will entitle the holder thereof to purchase one share of NorthView Common Stock at an exercise price of $11.50 per share. Additionally, there are 1,897,500 shares issuable pursuant to the 18,975,000 NorthView Rights outstanding. Therefore, as of the date of this proxy statement/prospectus (without giving effect to the Business Combination and assuming that none of NorthView’s outstanding public shares are redeemed in connection with the Business Combination), NorthView’s fully diluted capitalization would be 24,650,061shares of common stock. 119

The following summarizes the pro forma New Profusa common stock issued and outstanding immediately after the Business Combination, presented under the two redemption scenarios listed:

|                                                                                    |     | Pro Forma Combined 
       (Assuming No 
       Redemptions) |     |       |     | Pro Forma Combined 
  (Assuming Maximum 
    Redemptions)(1) |     |       |
| Shareholder                                                                        |     |             Shares |     |     % |     |             Shares |     |     % |